These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 664004)

  • 1. Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study.
    Stevens CE; Silbert JA; Miller DR; Dienstag JL; Purcell RH; Szmuness W
    Transfusion; 1978; 18(3):356-60. PubMed ID: 664004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.
    Amarapurkar DN; Kumar A; Vaidya S; Murti P; Bichile SK; Kalro RH; Desai HG
    Indian J Gastroenterol; 1992 Apr; 11(2):80-1. PubMed ID: 1428037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.
    Papaevangelou G; Frösner G; Economidou J; Parcha S; Roumeliotou A
    Br Med J; 1978 Mar; 1(6114):689-91. PubMed ID: 630296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.
    Gulati S; Marwaha RK; Dilawari JB; Midha U; Walia BN
    Indian Pediatr; 1992 Jan; 29(1):73-7. PubMed ID: 1601501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult HBV infection in multi transfused thalassemia patients.
    Sabat J; Dwibedi B; Dash L; Kar SK
    Indian J Pediatr; 2015 Mar; 82(3):240-4. PubMed ID: 24928107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.
    De Virgiliis S; Fiorelli G; Fargion S; Cornacchia G; Sanna G; Cossu P; Murgia V; Cao A
    J Clin Pathol; 1980 Oct; 33(10):949-53. PubMed ID: 7430360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HBsAg and anti-HBs in thalassemia non-transfused patients (and in their relatives)].
    Tannoia N; Putignano A; Cenci I; Colasuonno G; Dimonte D; Petrozzi L; Pastore G
    Boll Ist Sieroter Milan; 1978 May; 57(2):208-11. PubMed ID: 728269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions.
    Irshad M; Peter S
    Indian J Gastroenterol; 2002; 21(5):183-4. PubMed ID: 12416747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.
    Moroni GA; Piacentini G; Terzoli S; Jean G; Masera G
    Arch Dis Child; 1984 Dec; 59(12):1127-30. PubMed ID: 6441522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatitis B virus markers is not justified in West African transfusion centres.
    Ryder RW; Whittle HC; Wojiecowsky T; Moffat WM; Baker BA; Sarr E; Oldfield F
    Lancet; 1984 Aug; 2(8400):449-52. PubMed ID: 6147513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: Current prevalence and risk factors.
    Atwa ZT; Abdel Wahed WY
    J Infect Public Health; 2017; 10(6):870-874. PubMed ID: 28292647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of serum markers of infection and naturally acquired immunity to hepatitis B virus in transfused children treated at a children's hospital in Salvador, Bahia: A cross-sectional study.
    Martinez VO; D'Arede SO; de Almeida ES; Lima FWM
    Pediatr Hematol Oncol; 2018; 35(7-8):422-426. PubMed ID: 30588876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection in polytransfused patients with homozygous beta-thalassaemia.
    Papaevangelou G; Economidou J; Roumeliotou A; Adrachta D; Parcha S
    Vox Sang; 1979; 37(5):305-9. PubMed ID: 230639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients.
    Covas DT; Boturão Neto E; Zago MA
    Rev Inst Med Trop Sao Paulo; 1993; 35(3):271-3. PubMed ID: 8278757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic markers of hepatitis B and A infections in the healthy population.
    Sabău M; Kiss E; Muntean I; Căpîlnă E
    Virologie; 1983; 34(3):197-201. PubMed ID: 6636535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.